BR Biopharma (NASDAQ:BRBI) Trading Up 0.3% – Still a Buy?

Posted by Chris Copeland on Jul 25th, 2026

Shares of BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report) traded up 0.3% during trading on Friday . The company traded as high as $11.45 and last traded at $11.4860. Approximately 541 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 641 shares. The stock had previously closed at $11.45.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on BRBI

BR Biopharma Stock Performance

The company’s 50 day simple moving average is $11.97.

BR Biopharma (NASDAQ:BRBI – Get Free Report) last issued its earnings results on Tuesday, March 31st. The company reported $0.09 earnings per share for the quarter. The business had revenue of $25.95 million for the quarter.

BR Biopharma Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Shareholders of record on Tuesday, May 19th were issued a dividend of $0.147 per share. This represents a $0.59 dividend on an annualized basis and a yield of 5.1%. The ex-dividend date of this dividend was Tuesday, May 19th.

Hedge Funds Weigh In On BR Biopharma

An institutional investor recently bought a new position in BR Biopharma stock. Acuitas Investments LLC bought a new position in shares of BR Biopharma, Inc. (NASDAQ:BRBI – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma accounts for approximately 3.2% of Acuitas Investments LLC’s holdings, making the stock its 7th biggest position.

BR Biopharma Company Profile

(Get Free Report)

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.